• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Amicus Therapeutics Inc

+ Add to Watchlist

AM6:GR

1.311 EUR 0.100 7.09%

As of 02:01:40 ET on 04/16/2014.

Company Profile for Amicus Therapeutics Inc (AM6)

Amicus Therapeutics, Inc. is a biopharmaceutical company that develops orally-administered, small molecule drugs to treat human genetic diseases. The drugs, called pharmacological chaperones, are being developed to treat Fabray, Gaucher, and Pompe disease.

Contact Information

Amicus Therapeutics Inc

6 Cedar Brook Drive
Cranbury, NJ 08512
United States
Phone: 1-609-662-2000

Key Executives for Amicus Therapeutics Inc (AM6)

John F CrowleyChairman/CEOWilliam D Baird III "Chip"Chief Financial Officer
Bradley L CampbellChief Operating OfficerPeter M MacalusoVP/Secretary/Counsel
John R KirkVP:Regulatory AffairsKen ValenzanoVP:Pharmacology
Kenneth W PeistVP:Intellectual PropertyEnrique DiloneVP:Technical Operations
Sara PellegrinoDirector:Investor RelationsDaphne QuimiController

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil